Isodose debuts Flexiplan 2.5

Isodose Control has released its Flexiplan 2.5 brachytherapy planning system, which has CE Mark approval.

Eric van’t Hooft, president of Isodose, said that Flexiplan allows for the “fusion of different datasets, and can digitally reconstruct radiographs from CT images to give professionals complete patient information in one view, allowing fast and easy applicator reconstruction.”

Secondly, complex structures such as the trachea can now be identified as a single structure and contoured in multiple planes, which means volumes of complex structure can now be calculated in seconds, Hooft added.

Thirdly, Flexiplan supports new protocols, such as Mammosite, and includes improved optimization and calculation methods. Dose volumes are now automatically calculated in absolute values, such as cm3. The minimum/maximum surface dose detection can also be expressed in absolute values, according to the Ede, the Netherlands-based Isodose Control.

Previous features such as the zero-reference metric positioning system, smart user interface and offering real-time planning in the same package remain key in this new release, the company said.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.